Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.
暂无分享,去创建一个
Kelly K Hunt | W. Woodward | G. Hortobagyi | S. Singletary | K. Hunt | T. Buchholz | R. Theriault | S. Tucker | G. Perkins | E. Strom | Gabriel N Hortobagyi | S Eva Singletary | Thomas A Buchholz | Eric A Strom | George H Perkins | Wendy A Woodward | Susan L Tucker | Richard L Theriault | M. Mcneese | Marsha D McNeese | Naomi R Schechter | N. Schechter | Kelly K. Hunt | Susan L. Tucker | Thomas A. Buchholz | Richard Theriault
[1] G. Hortobagyi,et al. Trilostane with hydrocortisone in treatment of metastatic breast cancer , 1989, Breast Cancer Research and Treatment.
[2] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] E. Winer,et al. Lumping versus splitting: the splitters take this round. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] A. Buzdar,et al. Carcinoma of the Male Breast , 1992, Annals of Internal Medicine.
[5] Terry L. Smith,et al. Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs , 1988, Cancer.
[6] A R Feinstein,et al. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.
[7] Terry L. Smith,et al. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette‐Guerin and with or without irradiation in operable breast cancer a prospective randomized trial , 1984, Cancer.
[8] G. Hortobagyi,et al. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.